Our senior management team comprises leaders with significant industry experience and passion for our mission to be a global leader in test-consolidated third party quality control materials and real time peer review software solutions to meet the QC demands and requirements of the modern clinical laboratory. We have a track record of delivering on our goals and a commitment to our mission.
Malcolm Bell, Co-founder and Chief Executive Officer
Malcolm co-founded the Company in 2004 and was appointed CEO in 2011. He has successfully co-founded, developed and exited a number of life science and healthcare businesses based on novel technology and drawing on his over 20 years’ experience in these sectors. Malcolm brings extensive sales experience to the Company based on his strong scientific background. Malcolm leads the executive management team and business development activities of the Company while ensuring the business maintains its entrepreneurial and innovative focus. Previously, Malcolm was the co-founder and Joint Managing Director of Technopath (Distribution) which is now part of the Diploma plc group. Malcolm was educated at the National University of Ireland and holds a B.Sc. honours degree in Molecular Biology and a Master's Degree in Biotechnology.
Fergal Quinn, Chief Operating Officer
Fergal joined the company in September 2019. Fergal brings significant life sciences operations experience to Technopath. He has spent his entire career working in the pharmaceutical industry. He started his career with Pfizer in Ireland in the Technical Services Department and progressed through a number of roles of increasing responsibility as Head of Quality Control and subsequently Head of Quality Assurance and Regulatory Affairs. In 2007 Fergal joined Schering Plough working as head of Quality Assurance at their Active Pharmaceutical Ingredients facility in Singapore. In 2010 Fergal joined Merck, Sharpe and Dohme as Director of Operations for their Active Pharmaceuticals facility in Singapore. After 4 years in this role Fergal was appointed to the position of Executive Director for Quality overseeing all of Merck Sharpe and Dohme facilities in Singapore including API, Solid Oral Dosage, Sterile manufacturing and Inhalation devices. Most recently Fergal worked as Executive Director for Quality with responsibility for Drug Product formulation overseeing a number of sites in the EU and Asia. He holds a Bachelor of Sciences Degree in Chemistry and a Ph.D in synthetic organic chemistry from the National University of Ireland, Galway.
Peter Thornton, Chief Financial Officer
Peter joined the Company in 2014. He brings significant experience to the Company in the areas of finance, corporate and business development, M&A and financing in both public and private life science companies. Prior to this he served as SVP Business Integration for Alkermes plc, SVP, Corporate and Business Development for Elan Drug Technologies and CFO of Agenus Inc., a US based NASDAQ-listed biotechnology company. He currently serves as a non-executive director of NASDAQ listed Avadel Pharmaceuticals plc, leon-nanodrugs GmbH, Oculer Limited and Waverley Pharma Europe Limited. Peter has previously served as a Non-Executive Director of Merrion Pharmaceuticals plc, Agenus Inc., Cydex Pharmaceuticals Inc. and Valitacell Limited. Peter is a fellow of Chartered Accountants Ireland having worked with KPMG in Ireland and France. He holds a Bachelor of Commerce degree from University College Cork, Ireland.
Yuriy Kononyuk, Chief Informatics Officer, CIO
Yuriy successfully founded and developed LAQC Systems, Inc., a Canadian technology company with a primary focus on Quality Control/Quality Assurance data management in the clinical diagnostics laboratory market. He is the architect and developer of all LAQC software products, which have been successfully commercialised on a global basis directly or through partners. Yuriy has pioneered a new business model around QC/QA/PT data management. He brings significant experience to the Company in the areas of software development and the clinical diagnostics laboratory market. Yuriy holds a B.Sc. Honours degree in Mathematics and a Master’s Degree (Honours) in Computer Science.
Todd Leger, CEO Technopath Clinical Diagnostics USA Inc.
Todd joined the Company in 2017 bringing many years of in-vitro diagnostics sales, marketing, product development and management experience. For more than twenty years he was with Bio-Rad Laboratories in many different roles including the Director of Diagnostics Sales for the United States. Todd joins us directly from Mettler-Toledo, LLC where he served as the General Manager of U.S. Laboratory Business. Todd holds a Bachelor of Science degree in Biology with a minor in Chemistry from Stephen F. Austin State University and completed advanced business management studies at the University of California, Berkeley.
Conor Connolly, Vice President Commercial
Conor joined Technopath in 2011 and leads the Company’s commercial activities. He brings significant expertise in the areas of sales, business development and marketing, with particular experience in the In Vitro Diagnostic industry. Conor has held a number of roles in Technopath with increasing responsibility over 9 years. Conor started his career in Icon plc. as a technical specialist in the clinical trials laboratory. Conor was educated at Dublin City University and holds a B.Sc honours degree in Biotechnology.
Shane Huber, Co-founder and Chief Scientific Officer
Shane holds a Bachelor of Science in Biochemistry with a minor in Philosophy and Technical Writing from California State University, Fullerton and has 38 years experience working in Biochemistry. He began his career with Ortho Diagnostics in 1981 where he worked with a group that developed Uniqual, one of the first stable liquid quality control materials. He joined Bio-Rad in 1992 and served as Principal Scientist until he co-founded Technopath Clinical Diagnostics and developed the Multichem line of liquid, consolidated QC materials.
Brian Byrne, Vice President Operations – Environmental Technologies Division
Brian is an international executive with extensive senior managerial experience most recently in life sciences and regulated environmental waste treatment technologies. Brian leads Technopath’s Environmental Technologies Division, Envetec, covering all operational aspects of the business. During his career to date, Brian has gained extensive experience in chief executive and senior executive roles with public and private companies in Ireland, Australia, New Zealand, Scandinavia, the United States and Spain. Having first trained with KPMG in Dublin, Brian qualified as a Fellow of the Chartered Association of Certified Accountants and subsequently gained extensive experience across several industry sectors, including financial services, advertising, international fruit procurement, treasury, shipping, property and global trade logistics.
Michael Gilroy, Vice President Corporate Development
Michael joined the Company in 2015 and oversees new business developments, contract negotiations, funding negotiations and joint ventures. He also manages internal governance and regulatory compliance for the board of directors as well as the company’s intellectual property interests. Prior to joining Technopath, Michael worked in commercial law practices in Limerick and Dublin. He is a member of the Law Society in both Ireland and England & Wales and was appointed as a Notary Public in 2013. Prior to law school, Michael worked in the European Commission and also the European Parliament in Brussels. Michael carried out his studies at University College Galway and KU Leuven in Belgium and holds a Bachelor of Arts degree and Bachelor of Laws degree.
Bernd Hass, Vice President Quality and Regulatory Affairs
Bernd joined the Company in 2014. Bernd brings significant experience to the company in the area of Global Quality Compliance, GMP and technical expertise in the area of clinical diagnostics and biotechnology. Bernd held a number of positions of increasing responsibility over 11 years at Abbott Diagnostics in Ireland and Germany in the areas of Global Auditing, Technical Support, Validation and Operations. Prior to Abbott Diagnostics, Bernd was Lead Biotechnologist at Strathmann Biotec AG in Germany and R&D Lab Analyst for the DANISCO Cultor Group, Germany. Bernd attended Fresenius University in Idstein, Germany and received his Master's in Chemical Engineering.
Donal Tabb, Vice President of Finance
Donal joined the Company in 2015. Donal brings significant experience to the Company in the areas of finance, commercial activities and operations management with a strong track record in ERP implementations. Over the past 20 years, he has worked across a range of industries including pharmaceuticals, food and medical devices. Donal held a number of progressively senior finance and management roles with Dairygold Co-operative Society Limited (an international Food ingredients company with a turnover in excess of USD$1bn) where he worked for 9 years. Prior to this, Donal spent 7 years in senior finance roles with Clonmel Healthcare Limited, (part of Stada Pharmaceuticals AG). Donal started his career in Bausch & Lomb. Donal, a qualified management accountant, is a member of the Chartered Institute of Management Accountants and holds a Diploma in Leadership from University College Cork, Ireland.